CFS LLC’s AbbVie ABBV Stock Holding History

CFS LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-100	Closed	-$5K	–	124
2013 Q4	$5K	Buy	+100	New	+$4.92K	﹤0.01%	117

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

CFS LLC's ABBV Position: Q1 2014 in Review

CFS LLC sold out of AbbVie (ABBV) in Q1 2014, closing a stake of 100 shares — an estimated $5K sold.

CFS LLC first reported a position in ABBV in Q4 2013 and held it in 1 quarter. The position peaked at $5K in Q4 2013. 1,423 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

CFS LLC reported no remaining AbbVie position as of Q1 2014 after selling out during the quarter.
CFS LLC sold 100 AbbVie shares in Q1 2014, an estimated $5K.
CFS LLC first reported a position in AbbVie in Q4 2013 and held it in 1 quarter.
CFS LLC's AbbVie position peaked at $5K in Q4 2013.
1,423 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on CFS LLC's 13F filing for Q1 2014, filed 7 May 2014.